Korea Exchange announced on the 12th that it has approved the initial listing of Kanaph Therapeutics on the KOSDAQ market.


Kanaph Therapeutics will be listed in the KOSDAQ market's Technology Growth Division, with the stock code 'A0082N0'. Trading of Kanaph Therapeutics shares will begin on the 16th.



Kanaph Therapeutics, a company engaged in research and development in the fields of natural science and engineering, recorded annual sales of 4,251 million won and an operating profit of 4,722 million won in 2024. The listing underwriter is Korea Investment & Securities.

Seoul Headquarters of the Korea Exchange

Seoul Headquarters of the Korea Exchange

View original image


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing